Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27989

1.

Gold Nanoparticles-Decorated Hybrid Mesoflowers: An Efficient Surface-Enhanced Raman Scattering Substrate for Ultra-Trace Detection of Prostate Specific Antigen.

Panikkanvalappil SR, El-Sayed MA.

J Phys Chem B. 2014 Aug 21. [Epub ahead of print]

PMID:
25144402
[PubMed - as supplied by publisher]
2.

Application of guidelines to the evaluation of the male patient with urgency and/or incontinence.

Mangera A, Chapple C.

Curr Opin Urol. 2014 Aug 20. [Epub ahead of print]

PMID:
25144144
[PubMed - as supplied by publisher]
3.

Examining connections between screening for breast, cervical and prostate cancer and colorectal cancer screening.

Wirth MD, Brandt HM, Dolinger H, Hardin JW, Sharpe PA, Eberth JM.

Colorectal Cancer. 2014 Jun;3(3):253-263.

PMID:
25143785
[PubMed]
4.

<sup>89</sup>Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer.

Pandit-Taskar N, O'Donoghue JA, Beylergil V, Lyashchenko S, Ruan S, Solomon SB, Durack JC, Carrasquillo JA, Lefkowitz RA, Gonen M, Lewis JS, Holland JP, Cheal SM, Reuter VE, Osborne JR, Loda MF, Smith-Jones PM, Weber WA, Bander NH, Scher HI, Morris MJ, Larson SM.

Eur J Nucl Med Mol Imaging. 2014 Aug 21. [Epub ahead of print]

PMID:
25143071
[PubMed - as supplied by publisher]
5.

Association of anesthesia technique for radical prostatectomy with biochemical recurrence: a retrospective cohort study.

Ehdaie B, Sjoberg DD, Dalecki PH, Scardino PT, Eastham JA, Amar D.

Can J Anaesth. 2014 Aug 21. [Epub ahead of print]

PMID:
25141832
[PubMed - as supplied by publisher]
6.

Prostate cancer antigen-3 (PCA3) and PCA3-based nomograms in the diagnosis of prostate cancer: an external validation of Hansen's nomogram on a Norwegian cohort.

Nygård Y, Haukaas SA, Eide GE, Halvorsen OJ, Gravdal K, Frugård J, Akslen LA, Beisland C.

Scand J Urol. 2014 Aug 20:1-8. [Epub ahead of print]

PMID:
25141128
[PubMed - as supplied by publisher]
7.

White blood cell counts mediate the effects of physical activity on prostate-specific antigen levels.

Loprinzi PD, Richart SM.

Res Q Exerc Sport. 2014 Sep;85(3):409-13. doi: 10.1080/02701367.2014.930407.

PMID:
25141092
[PubMed - in process]
8.

Whole-Body 18F-Fluorocholine (FCH) PET/CT and MRI of the Spine for Monitoring Patients With Castration-Resistant Prostate Cancer Metastatic to Bone: A Pilot Study.

Balogova S, Zakoun JB, Michaud L, Khalil A, Tassart M, Esteso A, Kerrou K, Huchet V, Carette MF, Lotz JP, Talbot JN.

Clin Nucl Med. 2014 Aug 19. [Epub ahead of print]

PMID:
25140552
[PubMed - as supplied by publisher]
9.

Significance of atypical small acinar proliferation and extensive high-grade prostatic intraepithelial neoplasm in clinical practice.

Adamczyk P, Wolski Z, Butkiewicz R, Nussbeutel J, Drewa T.

Cent European J Urol. 2014;67(2):136-41. doi: 10.5173/ceju.2014.02.art4. Epub 2014 Jun 23.

PMID:
25140226
[PubMed]
10.

Primary Urothelial Carcinoma of the Prostate with Glandular Differentiation: A Case Report.

Lai P, Luo M, Hu G, Liu H, Xu L, Guo Z, Xu Y.

Urol Int. 2014 Aug 16. [Epub ahead of print]

PMID:
25139397
[PubMed - as supplied by publisher]
11.

Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study.

Fossati N, Buffi NM, Haese A, Stephan C, Larcher A, McNicholas T, de la Taille A, Freschi M, Lughezzani G, Abrate A, Bini V, Palou Redorta J, Graefen M, Guazzoni G, Lazzeri M.

Eur Urol. 2014 Aug 16. pii: S0302-2838(14)00686-1. doi: 10.1016/j.eururo.2014.07.034. [Epub ahead of print]

PMID:
25139197
[PubMed - as supplied by publisher]
12.

EMMPRIN and ADAM12 in prostate cancer: preliminary results of a prospective study.

Bilgin Doğru E, Dizdar Y, Akşit E, Ural F, Sanlı O, Yasasever V.

Tumour Biol. 2014 Aug 20. [Epub ahead of print]

PMID:
25139103
[PubMed - as supplied by publisher]
13.

Editorial Comment to Positron emission tomography/magnetic resonance imaging with <sup>68</sup> Gallium-labeled ligand of prostate-specific membrane antigen: Promising novel option in prostate cancer imaging?

Wetter A.

Int J Urol. 2014 Aug 19. doi: 10.1111/iju.12596. [Epub ahead of print] No abstract available.

PMID:
25138830
[PubMed - as supplied by publisher]
14.

Paget's disease of bone in ethnic thai presented with urologic symptoms and misleading as metastatic prostate cancer: report of a case with a review of the literature.

Sirikulchayanonta S, Jaovisidha S, Kongchareonsombat W, Sirikulchayanonta V.

J Med Assoc Thai. 2014 Jun;97(6):673-7.

PMID:
25137886
[PubMed - in process]
15.

Next-generation prostate-specific antigen test: precursor form of prostate-specific antigen.

Ito K, Fujizuka Y, Ishikura K, Cook B.

Int J Clin Oncol. 2014 Aug 20. [Epub ahead of print]

PMID:
25135462
[PubMed - as supplied by publisher]
16.

Deglycosylation of mAb by EndoS for Improved Molecular Imaging.

Gao P, Pinkston KL, Wilganowski N, Robinson H, Azhdarinia A, Zhu B, Sevick-Muraca EM, Harvey BR.

Mol Imaging Biol. 2014 Aug 19. [Epub ahead of print]

PMID:
25135058
[PubMed - as supplied by publisher]
17.

Serum levels of androgens and prostate-specific antigen in endometriosis.

Evsen MS, Sak ME, Soydinc HE, Guven S, Basaranoglu S, Hatipoglu NK, Evliyaoglu O, Gul T.

Clin Exp Obstet Gynecol. 2014;41(4):432-5.

PMID:
25134292
[PubMed - in process]
18.

Resource utilization and use of life-extending therapies and corticosteroids in prostate cancer patients with corticosteroid-sensitive comorbidities.

Bui CN, Wang L, Baser O.

Curr Med Res Opin. 2014 Aug 18:1-30. [Epub ahead of print]

PMID:
25133961
[PubMed - as supplied by publisher]
19.

Effect of histological inflammation on total and free serum prostate-specific antigen values in patients without clinically detectable prostate cancer.

Stimac G, Spajic B, Reljic A, Katusic J, Popovic A, Grubisic I, Tomas D.

Korean J Urol. 2014 Aug;55(8):527-32. doi: 10.4111/kju.2014.55.8.527. Epub 2014 Aug 8.

PMID:
25132947
[PubMed - in process]
Free PMC Article
20.

Predicting the Gleason sum of a patient with a prostate biopsy core Gleason ≤7 and a prostate biopsy core Gleason ≥8.

Heimrath OP, Kos Z, Belanger EC, Cagiannos I, Morash C, Gerridzen RG, Lavallée LT, Preston MA, Witiuk K, Breau RH.

Can Urol Assoc J. 2014 Jul;8(7-8):E476-80. doi: 10.5489/cuaj.1737.

PMID:
25132892
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk